AIBP-Mediated Cholesterol Efflux and Angiogenesis
AIBP 介导的胆固醇流出和血管生成
基本信息
- 批准号:9178668
- 负责人:
- 金额:$ 24.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-11-07 至 2018-10-31
- 项目状态:已结题
- 来源:
- 关键词:ATP binding cassette transporter 1ATP-Binding Cassette TransportersAdultAnimalsAortaApolipoprotein A-IArteriesAttenuatedBinding ProteinsCardiacCardiac MyocytesCholesterolCholesterol HomeostasisCoronaryDorsalEctopic ExpressionEmbryoEmbryonic DevelopmentEndothelial CellsFishesGoalsHeartHeart HypertrophyHigh Density LipoproteinsHumanIn VitroKnockout MiceMammalsMeasuresMediatingMentorsMetabolismMicrocirculationMicrocirculatory BedMolecularMorbidity - disease rateMusMyocardial InfarctionMyocardiumNatural regenerationPathologicPhasePhenocopyPhenotypePlayProtein DeficiencyProtein OverexpressionProteinsRecoveryReperfusion TherapyResearchResectedResourcesRoleSiteSupervisionTestingTherapeuticTherapeutic InterventionTransgenic OrganismsTransplantationUnited StatesVeinsZebrafishangiogenesisbasecardiac angiogenesiscardiac regenerationcholesterol transportersconstrictionembryo monitoringexperimental studyimprovedknock-downmortalityoverexpressionpreventprotein expressionprotein functionreconstitutionrepairedrestorationtissue regeneration
项目摘要
Project Summary
Myocardial infarction is the leading cause of mortality and morbidity in the US. Following reperfusion,
angiogenesis and restoration of microcirculation is a critical component in the recovery of normal cardiac
function. Angiogenesis is also important for zebrafish heart regeneration. Much progress has been made
towards understanding of the molecular mechanisms of angiogenesis, but the connection between metabolism
and angiogenesis is less studied. My preliminary studies strongly suggest that cholesterol efflux from
endothelial cells regulates angiogenesis. I found that angiogenesis in vitro and in embryonic zebrafish was
regulated by ApoA-I binding protein (AIBP), a secreted protein identified in a screen of proteins that physically
associate with ApoA-I. AIBP accelerated ABCG1-mediated cholesterol efflux from endothelial cells (EC) in
vitro. Furthermore, AIBP controlled formation of segmental arteries (SeA) in embryonic zebrafish.
Overexpression of AIBP inhibited SeA sprouting, while AIBP knockdown resulted in dysregulated SeA
sprouting and branching. In my mentored K99 phase, I propose to test the hypothesis that secreted AIBP
functions as a site-specific regulator of cholesterol efflux from EC and governs embryonic angiogenesis. First, I
plan to demonstrate that AIBP-mediated, ABC transporters-dependent cholesterol efflux regulates embryonic
angiogenesis in zebrafish. I found that the phenotype caused by the loss of AIBP was phenocopied by
knockdown of cellular cholesterol transporters ABCA1 and ABCG1. My goal in this Aim is to prove that the
effect of AIBP on embryonic angiogenesis relies on the AIBP function in cholesterol metabolism. These studies
will establish a previously unrecognized mechanism connecting cholesterol efflux with embryonic
angiogenesis. Then in my independent R00 phase, I will demonstrate that AIBP overexpression in adult
zebrafish attenuates heart regeneration. Formation of coronary vasculature is believed to be important for
heart regeneration because it conceivably provides resources necessary for robust proliferation of
cardiomyocytes. I will make an AIBP conditional expression transgenic fish line, and investigate the impact of
AIBP overexpression on angiogenesis that occurs during zebrafish heart regeneration. My second Aim in the
independent R00 phase is to assess that AIBP expression modulates coronary angiogenesis in mice. Because
my results suggest that AIBP limits angiogenesis, I propose that cardiomyocyte-specific loss of AIBP would
promote angiogenesis under conditions of cardiac hypertrophy. These studies will elucidate a potential role for
AIBP-governed angiogenesis in heart regeneration and in cardiac hypertrophy and suggest possible
therapeutic interventions to stimulate the recovery of the microvasculature by promoting angiogenesis.
项目概要
心肌梗塞是美国死亡和发病的主要原因。再灌注后,
血管生成和微循环的恢复是恢复正常心脏功能的关键组成部分
功能。血管生成对于斑马鱼心脏再生也很重要。已经取得了很大进展
有助于理解血管生成的分子机制,但代谢之间的联系
对血管生成的研究较少。我的初步研究强烈表明胆固醇从
内皮细胞调节血管生成。我发现体外和胚胎斑马鱼的血管生成是
受 ApoA-I 结合蛋白 (AIBP) 调节,AIBP 是一种在蛋白质筛选中鉴定出的分泌蛋白,该蛋白质在物理上
与 ApoA-I 相关。 AIBP 加速 ABCG1 介导的胆固醇从内皮细胞 (EC) 流出
体外。此外,AIBP 控制胚胎斑马鱼节段动脉 (SeA) 的形成。
AIBP 的过表达抑制 SeA 萌芽,而 AIBP 敲低则导致 SeA 失调
发芽和分枝。在我指导的 K99 阶段,我建议检验分泌 AIBP 的假设
作为从 EC 流出的胆固醇的位点特异性调节剂并控制胚胎血管生成。首先,我
计划证明 AIBP 介导的 ABC 转运蛋白依赖性胆固醇流出调节胚胎
斑马鱼的血管生成。我发现 AIBP 缺失引起的表型是由
细胞胆固醇转运蛋白 ABCA1 和 ABCG1 的敲低。我的目标是证明
AIBP对胚胎血管生成的影响依赖于AIBP在胆固醇代谢中的功能。这些研究
将建立一个以前未被认识的机制,将胆固醇流出与胚胎联系起来
血管生成。然后在我的独立 R00 阶段,我将证明 AIBP 在成人中过度表达
斑马鱼会减弱心脏再生。冠状动脉血管系统的形成被认为对于
心脏再生,因为它可以为心脏的强劲增殖提供必要的资源
心肌细胞。我将制作一个AIBP条件表达转基因鱼系,并研究其影响
AIBP 过度表达对斑马鱼心脏再生过程中发生的血管生成的影响。我的第二个目标
独立R00阶段的目的是评估AIBP表达调节小鼠冠状动脉血管生成。因为
我的结果表明 AIBP 限制了血管生成,我认为心肌细胞特异性的 AIBP 损失会
在心脏肥大的情况下促进血管生成。这些研究将阐明其潜在作用
AIBP 控制心脏再生和心脏肥大中的血管生成,并表明可能
通过促进血管生成来刺激微脉管系统恢复的治疗干预措施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Longhou Fang其他文献
Longhou Fang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Longhou Fang', 18)}}的其他基金
Flow, Fatty Acid Biosynthesis, and Hematopoiesis
流动、脂肪酸生物合成和造血
- 批准号:
10868960 - 财政年份:2023
- 资助金额:
$ 24.29万 - 项目类别:
AIBP Mediates a Novel Interplay between Cholesterol Metabolism and Lymphangiogenesis
AIBP 介导胆固醇代谢和淋巴管生成之间的新相互作用
- 批准号:
9247254 - 财政年份:2016
- 资助金额:
$ 24.29万 - 项目类别:
AIBP-Mediated Cholesterol Efflux and Angiogenesis
AIBP 介导的胆固醇流出和血管生成
- 批准号:
8929458 - 财政年份:2014
- 资助金额:
$ 24.29万 - 项目类别:
AIBP-mediated Cholesterol Efflux and Angiogenesis
AIBP 介导的胆固醇流出和血管生成
- 批准号:
8353288 - 财政年份:2012
- 资助金额:
$ 24.29万 - 项目类别:
AIBP-Mediated Cholesterol Efflux and Angiogenesis
AIBP 介导的胆固醇流出和血管生成
- 批准号:
8528713 - 财政年份:2012
- 资助金额:
$ 24.29万 - 项目类别:
相似国自然基金
基于超声多模态评价技术探讨肝脏靶向递送ABCA1新策略在动脉粥样硬化防治中的应用
- 批准号:81871357
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
基于SIRT1-LXR通路的化合物E4023抗动脉粥样硬化的作用及机制研究
- 批准号:81703503
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
基于LXRα-SREBP1-ABCA1/G1信号通路的益气活血化痰方调脂抗动脉粥样硬化机制研究
- 批准号:81774088
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
肝脏X受体激动剂干预β淀粉样蛋白诱导的视网膜炎性反应的作用及机制
- 批准号:81670881
- 批准年份:2016
- 资助金额:51.0 万元
- 项目类别:面上项目
新型ABCA1上调剂E17241改善糖脂代谢紊乱的机制研究
- 批准号:81573482
- 批准年份:2015
- 资助金额:50.0 万元
- 项目类别:面上项目
相似海外基金
Insulin Regulation of Liver X Receptor in Normal and Insulin Resistant States
正常和胰岛素抵抗状态下肝脏 X 受体的胰岛素调节
- 批准号:
9306322 - 财政年份:2016
- 资助金额:
$ 24.29万 - 项目类别:
Analysis of the macrophage membrane proteome: effects of viral infection
巨噬细胞膜蛋白质组分析:病毒感染的影响
- 批准号:
8969989 - 财政年份:2015
- 资助金额:
$ 24.29万 - 项目类别:
Analysis of the macrophage membrane proteome: effects of viral infection
巨噬细胞膜蛋白质组分析:病毒感染的影响
- 批准号:
9069731 - 财政年份:2015
- 资助金额:
$ 24.29万 - 项目类别:
ABCA1 regulates white matter remodeling and oligodendrogenesis after stroke
ABCA1 调节中风后白质重塑和少突胶质细胞生成
- 批准号:
8944748 - 财政年份:2015
- 资助金额:
$ 24.29万 - 项目类别:
AIBP-Mediated Cholesterol Efflux and Angiogenesis
AIBP 介导的胆固醇流出和血管生成
- 批准号:
8929458 - 财政年份:2014
- 资助金额:
$ 24.29万 - 项目类别: